Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Pachymeningitis

quinazolines has been researched along with Pachymeningitis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HC; Dou, BB; Fu, JY; Liu, WT; Miao, L; Tan, C; Wang, XR; Yang, B; Yang, RC; Yang, XP; Zhang, T1
Dhruva, N; Socinski, MA1
Choi, JH; Hyun, MS; Kim, MK; Lee, JK; Lee, KH1
Breau, JL; Brechot, JM; Chouahnia, K; Des-Guetz, G; Morere, JF; Saintigny, P1
Ishikawa, S; Ito, H; Onizuka, M; Ozawa, Y; Sakai, M; Sakakibara, Y; Yamamoto, T1
Fukuhara, T; Inoue, A; Kanamori, M; Morikawa, N; Nakashima, I; Nukiwa, T; Saijo, Y; Sakakibara, T1

Other Studies

6 other study(ies) available for quinazolines and Pachymeningitis

ArticleYear
EGFR transactivation contributes to neuroinflammation in Streptococcus suis meningitis.
    Journal of neuroinflammation, 2016, 10-19, Volume: 13, Issue:1

    Topics: Amphiregulin; Animals; Brain; Cytokines; Endothelial Cells; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Meningitis; Mice; Phosphorylation; Quinazolines; Receptor, ErbB-3; Signal Transduction; Streptococcal Infections; Streptococcus suis; Swine; Transcriptional Activation; Tyrosine; Tyrphostins

2016
Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Aug-01, Volume: 27, Issue:22

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Disease Progression; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Fatal Outcome; Female; Humans; Immunohistochemistry; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningitis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Quinazolines; Risk Assessment; Tomography, X-Ray Computed

2009
Gefitinib is also active for carcinomatous meningitis in NSCLC.
    Lung cancer (Amsterdam, Netherlands), 2005, Volume: 50, Issue:2

    Topics: Carcinoma, Non-Small-Cell Lung; Gefitinib; Humans; Lung Neoplasms; Male; Meningitis; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Spinal Cord Neoplasms; Treatment Outcome

2005
[Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
    Revue des maladies respiratoires, 2006, Volume: 23, Issue:2 Pt 1

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Meningitis; Middle Aged; Neoplasm Proteins; Paclitaxel; Palliative Care; Pneumonectomy; Protein Kinase Inhibitors; Quinazolines; Vinblastine; Vinorelbine

2006
Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
    International journal of clinical oncology, 2006, Volume: 11, Issue:3

    Topics: Adult; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Gefitinib; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Meningitis; Quinazolines

2006
Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.
    The Tohoku journal of experimental medicine, 2008, Volume: 214, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Combined Modality Therapy; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Meningitis; Middle Aged; Mutation; Quinazolines; Radiotherapy

2008